Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 26, 1999

View Archived Issues

Crescendo submits two NDAs to FDA during Q3 1999

MGI Pharma makes significant progress with MGI-114 development during third quarter

Protease inhibitors for HCV infection developed at Vertex

Trademark verdict disputed by Pfizer

CDC advisory committee recommends Wyeth-Lederle's pneumococcal conjugate vaccine for routine use

Sheffield Pharmaceuticals completes inhaled steroid agreement with Elan

FP receptor agonists claimed by Procter & Gamble for bone disorders, glaucoma

New antitumor diterpenes discovered in China

Chinese researchers isolate new immunosuppressive fungal metabolite

PTPase inhibitors in early development at Novo Nordisk

Novel oncological compounds acting as antagonists of protein-carbohydrate binding

Merck's new GH secretagogues described in recent patent

Polyamine derivatives designed at U. of Florida for reduced toxicity

Patents cover Immtech's lead dicationic antifungal agents

Immtech receives patent coverage for rmCRP in platelet disorders

Agouron to commercialize Rescriptor throughout the world; anti-HIV pipeline grows

Development of OvaRex is now sole focus for AltaRex

Pharmacia & Upjohn reviews recent FDA developments for its products

Recent steps taken toward creation of Aventis

Antiepileptic potential of EPC-K1 demonstrated in rat model

LMW heparin to be marketed in U.K. and Ireland by ICN

First approval obtained for bivalirudin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...